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Summary
INTRODUCTION: In general practice, the diagnosis of de-
mentia is often delayed. Therefore, the Swiss National De-
mentia Strategy 2014 concluded that action was needed
to improve patient care. Little is known about GPs’ con-
fidence in and approach to the diagnosis, disclosure and
post-diagnostic management of individuals with dementia
in Switzerland. The aim of this survey is to assess these
elements of dementia care and GPs’ views on the adequa-
cy of health care services regarding dementia.
MATERIALS AND METHODS: Cross-sectional postal sur-
vey in Switzerland in 2017 supported by all academic in-
stitutes of general practice in Swiss universities. Mem-
bers of the Swiss Association of General Practitioners (n =
4460) were asked to participate in the survey. In addition
to the GPs’ demographic characteristics, the survey ad-
dressed the following issues: GPs’ views on the adequacy
of health care services, clinical approach and confidence
in the management of dementia.
RESULTS: The survey response rate was 21%. The ma-
jority of GPs (64%) felt confident diagnosing dementia, but
not in patients with a migration background (15%). For
neuropsychological testing, three-quarters of GPs collab-
orated with memory clinics and were satisfied with the ac-
cess to diagnostic services. At the time of first diagnosis,
62% of GPs diagnosed the majority of their patients with
a mild stage of dementia, and 31% with a mild cognitive
impairment. The most frequent actions taken by GPs after
the diagnosis of mild dementia were giving advice to rel-
atives (71%), testing fitness-to-drive (66%) and minimis-
ing cardiovascular risk factors (63%). While 65% of GPs
felt confident taking care of patients with dementia, few-
er (53%) felt confident in pharmacological treatment, cop-
ing with suicidal ideation (44%) or caring for patients with
a migration background (16%). Half of GPs preferred to
delegate the assessment of fitness-to-drive to an official
authority. One in four GPs was not satisfied with the local
provision of care and support facilities for patients with de-
mentia.
CONCLUSIONS: Overall, GPs reported confidence in es-
tablishing a diagnosis of dementia and sufficient access to
diagnostic services. Post-diagnostic management primar-
ily focused on counselling and harm reduction rather than
pharmacological treatment. Future educational support for
GPs should be developed, concentrating on coping with
their patients’ suicidal ideation and caring for patients with
a migration background.
Keywords: dementia, cognition, general practitioners,
health services research, diagnosis
Introduction
General practitioners (GPs) typically play a key role in
timely dementia diagnosis and on-going care of their pa-
tients with dementia. However, there is evidence that the
diagnosis of dementia is insufficient in general practice [1],
resulting in delayed detection of dementia and disadvan-
tages for patients and their caregivers [2, 3]. In Switzer-
land, the detection rate of cognitive impairment by GPs in
an elderly population is low, ranging from 24 to 42% in
out-patients [4]. A European key informant survey indicat-
ed that the majority of GPs in Switzerland tried to estab-
lish a diagnosis of dementia on their own, and only half of
them referred a suspected case of dementia to a secondary
care specialist [5]. Evidence suggests that disease disclo-
sure does not routinely occur in general practice, despite
the fact that it may help patients with dementia and their
caregivers with future planning [6, 7], and that GPs are re-
luctant to speak openly with their patients about dementia
[8, 9].
Many reasons why a timely dementia diagnosis might be
challenging for GPs are reported in the literature. Typical
barriers include the lack of time during consultations [5],
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particularly in combination with multiple health issues in
older patients [10]. There is evidence that GPs have diffi-
culty conveying the diagnosis when the patient and his/her
caregiver are unaware of the symptoms of cognitive de-
cline [10], there is no informant history available [11–13],
when GPs lack the training to detect early signs of demen-
tia [14] or when the presenting symptoms are vague [15].
Further obstacles for GPs include their own feelings of
uneasiness about carrying out cognitive examinations and
difficulties in communicating the diagnosis [16], as well as
a lack of patient-centeredness in their diagnostic approach
[17]. Moreover, GPs may think that nobody stands to ben-
efit from an early diagnosis because no effective treatment
is available [18].
There is also evidence of shortcomings in the health care
system and the possibility of support for persons with de-
mentia and their families. In particular, studies have re-
vealed problems with late referral to specialist and social
services [19], difficulties accessing and communicating
with specialists, GPs’ lack of time, low reimbursement and
a lack of interdisciplinary teams [20]. Further constraints
include delayed detection of behavioural problems, a lack
of proactive management of dementia and an increased re-
liance on pharmacological rather than psychosocial treat-
ment strategies [20]. Another study found a lack of coun-
selling ability about safety and accident prevention in GPs
and a lack of caregiver support and conflict management
[21]. It is important that GPs are aware of all local re-
sources to alleviate the burden on the patient and his/her
caregivers, particularly in the absence of disease modify-
ing therapies [20, 22].
Improving early detection of dementia was one of the aims
in the Swiss National Dementia Strategy 2014–2017, be-
cause there are multiple benefits for patients, families and
resources [23]. Examining GPs’ approach to the manage-
ment of dementia is critical for the planning and develop-
ment of services.
Thus, the aim of this study is to explore GPs’ approach
to the diagnosis, disclosure and management of dementia,
and their perception of the provision of care and health
services for individuals with dementia via a national sur-
vey. In particular, this study set out to examine (i) diag-
nosis and disclosure practice, (ii) frequency of different
treatment options in a case vignette of mild dementia, (iii)
GPs’ satisfaction with post-diagnostic dementia services
and (iv) GPs’ confidence in different areas of dementia
management. Since findings may differ regionally due to
political, cultural or residential factors, findings on the de-
mand for dementia-specific health care services were as-
sessed across different regional characteristics.
Materials and methods
Study design and setting
The Centre for Primary Health Care of the University of
Basel undertook a national study among GPs across
Switzerland in 2017 to measure GPs’ attitudes, practice
and confidence in caring for patients with dementia, and
mild dementia in particular. The survey was part of an ob-
servational, cross-sectional study entitled “General practi-
tioners dementia report Switzerland.”
Sampling and data collection
All GPs who are members of “mfe” (Swiss Association of
General Practitioners and Paediatricians, n = 4460) were
contacted by mail in August 2017 and asked to participate
in the survey. Paediatricians (n = 450) were excluded from
the survey. The letter included a recommendation from all
institutes of general practice in Switzerland encouraging
the addressees to take part in the study, study information
with a link to the online questionnaire, a questionnaire and
a stamped, addressed envelope to return the study docu-
ments. Since the survey was anonymous, a reminder was
sent to all members by e-mail 1 month later.
Measures
The questionnaire assessed GPs’ practice in caring for pa-
tients with dementia and comprised 66 items in total. The
initial questionnaire was developed in German. Content
validity was pre-tested among a small group of physicians
for readability and acceptability (two of them are listed
as authors). Two independent translations into French and
Italian were made by professional translators. Translations
were assessed by members of the study team. GPs were
required to specify their age and gender, the location of
their practice (rural, urban or agglomeration of a city and
the canton), the year in which they started working in their
practice, their satisfaction with dementia-specific educa-
tion, the average hours of work per week (patient contact
and administration) and the number of patient consulta-
tions per half day. GPs were also asked to estimate the per-
centage of their patients over the age of 70.
The items were mostly based on previous questionnaires
such as the final report of the “Joint Action on Alzheimer
Cooperation Valuation in Europe” (ALCOVE) on timely
diagnosis of dementia [24], two questionnaires about GPs’
attitudes to dementia [25, 26], or otherwise developed by
the authors of the study as indicated below. The items
comprised GPs’ use of diagnostic tools [24], diagnostic
collaborations with other specialists [24], GPs’ need for
care facilities for dementia patients [25] and their care-
givers in the practice’s local area, and the stage of dementia
at the moment of diagnosis [24]. GPs’ confidence in the
diagnosis, treatment and care of patients with dementia,
with or without a migration background, was also assessed
[25, 26]. From a theoretical perspective, a migration back-
ground can be understood as a life situation characterised
by one's own migration or the migration experience of
close family members. The biographical event of a mi-
gration may result in peculiarities in life situation which
can, among other effects, be relevant to health, leading to
health differences between the native and the migrant pop-
ulations [27, 28]. Additional questions created by the core
study team (KB, SG, AUM) were incorporated, such as
on the disclosure process and reasons for the diagnostic
assessment. Furthermore, GPs’ treatment strategies were
assessed in a case vignette. The vignette comprised the
question “What measures would you take if a patient was
diagnosed with early stage Alzheimer's disease (MMSE of
24 and needing some assistance in activities of daily liv-
ing)?”, since that is the disease stage that GPs see most of-
ten. GPs were asked to rate the frequency of each item on
a 5-point Likert scale (see table S1 in appendix 1 and fig.
2).
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Most answers were assessed on a 5-point Likert scale from
strongly disagree (1) to partially agree (3) to strongly agree
(5) or from always (100%) to half (50%) to never (0%).
Multiple answers were possible for certain items, e.g.
when GPs had to choose from a set of seven different cog-
nitive assessment tools.
Statistical analyses
All data analyses were conducted using R version 1.3 [29].
Descriptive results were provided across the whole sample
using number and percentage (%) for categorical data or
mean and standard deviation (SD) for continuous data. An-
swers on five-point Likert scales such as “agree/strongly
agree” and “disagree/fully disagree” were grouped togeth-
er. We then reported the sum of the two percentages. Ad-
ditionally, we summarised the Likert scales with their me-
dian (Mdn) and interquartile range (IQR) (see appendix 1).
Regional patterns in dementia management across Switzer-
land were displayed using the function “spplot” from the
R package “sp”. The percentages or medians of variables
were displayed across cantons or municipality. To assess
the relationship between regional characteristics and GPs’
provision with diagnostic assessment possibilities or care,
Pearson's chi-squared test was used. Regional differences
encompassed urban and rural areas (city, agglomeration of
a city, countryside), seven major Swiss regions (see table
1) [30] and three language regions (German, French, Ital-
ian). Statistical significance was set at the 5% level.
Results
Sample
Of the 4460 initially contacted GPs, 306 were either no
longer practicing as a GP or the letter was undeliverable,
leaving a sample of 4154 GPs. A total of 882 GPs (21%)
returned the questionnaire. We found no strong evidence
for a non-responder bias for gender (p = 0.62) but did find
a small over-representation of German-speaking GPs (79%
in the survey, 75% in the population, p = 0.046). The de-
mographic, regional and professional characteristics of the
resulting total sample of 882 GPs are presented in table 1.
In terms of responder participation, the survey covered all
regions across Switzerland.
GPs’ diagnosis and disclosure practice
More than half of GPs (57%) stated that caring relatives of-
ten asked for a diagnostic assessment having noticed cog-
nitive impairment or behavioural changes. Approximate-
ly half of respondents reported that cognitive impairment
or behavioural changes were frequently noticed by patients
(49%) or by GPs themselves (45%). A third of GPs initi-
ated a diagnostic assessment due to an official cause such
as a fitness-to-drive assessment or establishing a last will
document. Eight percent of GPs initiated a diagnostic as-
sessment in the context of a screening test, meaning that
they “proactively” asked older patients at risk of dementia
about their memory and offered a screening test (see table
S1, appendix 1).
Sixty-four percent of GPs felt confident in the early di-
agnostic assessment of patients with cognitive impairment
(only 10% did not, 26% felt partially confident, see table
S2, appendix 1). However, half of the respondent GPs felt
unconfident in carrying out an early diagnostic assessment
if their patients had a migration background. While 10%
of GPs felt unconfident in the early diagnostic assessment
of patients with cognitive impairment, up to 52% felt un-
confident when patients had a migration background (table
S2). The most frequently used tests to assess cognitive im-
pairment and the specialist with whom GPs worked for the
diagnostic assessment are reported in table 2.
Three-quarters of GPs were satisfied with the access to
diagnostic services such as memory clinics or referral to
specialists. Only 13% of respondents reported having in-
sufficient access (see table S3, appendix 1). There was a
significant difference in terms of access to diagnostic ser-
vices between language regions (χ2 = 79.3, df = 8, p <
0.001) (fig. 1) but not between rural and urban regions (χ2
= 11.6, df = 8, p = 0.167). French-speaking GPs were less
satisfied with their access to diagnostic services compared
with German-speaking GPs. In particular, GPs of the can-
ton Valais (n = 19) were on average only partially satis-
fied with the provision of diagnostic assessment possibili-
ties (table 2).
Three-quarters of respondents reported often disclosing the
diagnosis themselves. Only 9% of respondents almost nev-
er or never disclosed the diagnosis themselves (table S1).
The disclosure usually took place with the patient and their
relatives (89.6%), and less often with the patient alone
Table 1: Demographic, regional and professional characteristics of the
respondent GPs (n = 822).
Variable n* (%)
Gender (male) 617 (70.0)
Age (years) (mean, SD) 55.8 (8.86)
Language region
German 692
(78.5)
French 151
(17.1)
Italian 39 (4.42)
Major Swiss regions
Lake Geneva (GE, VS, VD) 106 (12.3)
Middle Switzerland (BE, SO, FR, NE, JU) 216 (25.1)
Northwestern Switzerland (BS, BL, AG) 161 (18.7)
Eastern Switzerland (SG, TG, AI, AR, GL, SH, GR) 130 (15.1)
Ticino (TI) 38 (4.41)
Central Switzerland (UR, SZ, OW, NW, LU, ZG) 72 (8.35)
Zurich (ZH) 140 (16.2)
Type of area in which practice is located
City 297 (34.0)
Agglomeration of a city 274 (31.4)
Country side 302 (34.6)
Numbers of years practicing in practice 20.0 (9.92)
Average hours of work per week (patients and admin-
istration) (mean, SD)
46.0 (14.2)
No. of consultations per half day (mean, SD) 12.94 (4.74)
Estimate of the percentage of patients over the age of
70 (mean, SD)
36.3 (17.5)
SD = standard deviation Swiss cantons: GE Geneva, VS Valais, VD
Vaud, BE Bern, SO Solothurn, FR Fribourg; NE Neuchâtel, JU Jura, BS
Basel-City, BL, Basel-Country, AG Aargau, SG St Gallen, TG Thurgau,
AI I Appenzell Innerrhoden, AR Appenzell Ausserrhoden, GL Glarus,
SH Schaffhausen, GR Grisons, TI Ticino, Ur Uri, SZ Schwyz, OW Ob-
walden, NW Nidwalden, LU Luzern, ZG Zug, ZH Zurich * If not other-
wise specified number of responders (n) and percentage of total (%)
are reported.
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(9.9%). This consultation lasted 28.5 minutes (SD = 11.9)
on average. The most frequent stage of dementia at the mo-
ment of first diagnosis was mild dementia with an MMSE
of 20-30 and difficulties in activities of daily living
(62.5%). Thirty-one percent of respondents reported that
MCI is the most frequent stage of dementia at diagnosis.
Only 6.2% of GPs reported that the stage of dementia at
the moment of diagnosis was moderate with a MMSE of
10-19.
GPs’ post-diagnostic strategies and interventions in
early dementia
In the case vignette of a patient diagnosed with mild de-
mentia, the most commonly implemented strategies were
to counsel relatives (71% frequent and always), to test fit-
ness-to-drive (66% frequent and always) and to minimise
cardiovascular risks (63% frequent and always) (fig. 2 and
table S4, appendix 1). The least used measures were phar-
macological therapy with either acetylcholinesterase in-
hibitors or memantine (29% frequent and always), a wait-
and-see strategy with no intervention (watchful waiting)
Table 2: Diagnostic tools and specialist allies to assess cognitive im-
pairment.
Variables n %
(of the total n =
882)
Tests
Mini-Mental-Status-Examination
(MMSE)
749 84.9
Clock Drawing Test 739 83.8
Trail Making Test (A and B) 386 43.8
Montreal Cognitive Assessment (Mo-
CA)
149 16.9
DemTect 52 5.9
BrainCheck (as a case-finding tool) 52 5.9
CERAD-Neuropsychological Battery 18 2.0
Specialists
Memory Clinic (outpatient) 668 75.7
Neurology (outpatient) 334 37.9
Neuropsychology (outpatient) 287 32.5
Geriatrics (outpatient) 161 18.3
Psychiatry (outpatient) 118 13.4
Geriatrics (inpatient) 85 9.6
Neurology (inpatient) 21 2.4
Psychiatry (inpatient) 21 2.4
(21% frequent and always), to send patients to other thera-
pies involving music, painting, dancing or coaching (21%
frequent and always) and home visits to assess specific
living conditions (12% frequent and always). The use of
pharmacological combination therapy with acetyl-
cholinesterase inhibitors and memantine was almost never
implemented (3%). GPs planned a follow up visit after an
average of 3.7 months (SD = 2.3). While 53% of respon-
dents felt confident in pharmacological therapy, 18% did
not feel confident in this domain and the rest felt partially
confident (29%). Moreover, almost half of the respondent
GPs would like to delegate the assessment of fitness-to-dri-
ve of patients with cognitive impairment to an official au-
thority, while 36% did not want to do so.
Care and support of patient with dementia
Two-thirds of GPs felt confident caring for and supporting
their patients. Only 7% of GPs felt unconfident caring for
and supporting their patients with dementia (table S2, ap-
pendix 1). However, in caring for patients with a migra-
tion background, only 16% of GPs felt confident and 49%
of respondents stated that they did not feel confident with
these patients (table S2). Thirty percent of respondents felt
unconfident handling suicidal ideation of patients with ear-
ly dementia (table S2). Half of the respondents considered
the local provision of care and support facilities as suffi-
cient. However, there was some evidence for regional dif-
Figure 2: Boxplots of frequency of actions after the diagnosis of
mild dementia. The frequency of taking a certain measure is mea-
sured numerically in percent with 100% meaning always, 50%
meaning in half of the cases and 0% meaning never. AChEI:
acetylcholinesterase inhibitor, AD: Alzheimer’s dementia
Figure 1: Boxplot (left) and map (right) of satisfaction with the access to diagnostic assessment possibilities for patients with cognitive impair-
ment across language region. The map displays the median agreement across cantons. ++ = strongly agree (satisfied), +/- partially agree, --
strongly disagree (not satisfied)
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ferences in the perception of the provision of care facilities
across the seven major Swiss regions (χ2 = 37.3, df = 24, p
= 0.041), but not across language regions or the urban-rur-
al regions. In particular, GPs in the rural cantons of Jura (n
= 7) and Uri (n = 2) reported insufficient provision of care
facilities (fig. 3), while the regions of Geneva, North West
Switzerland, Tessin and Zürich reported sufficient health
care facilities.
GPs stated that memory training (46.4%), vacation offers
(43.4%), night care (43.0%) and day care (41.3%) were
needed (see table S5, appendix 1). GPs who declared that
the provision of care facilities was insufficient (n = 218)
most often required day care (58.3) and memory training
(58.3) as well as night care (50.9).
Discussion
This survey of GPs in Switzerland has revealed a very pos-
itive approach to dementia care, with more than 60% of re-
spondents feeling confident in diagnosing dementia and in
caring and supporting patients with dementia. Health ser-
vices were considered sufficient; three-quarters of respon-
dents stated that there was sufficient access to diagnostic
services for referring patients with cognitive impairment,
and half of respondents stated that the regional provision
of care facilities was sufficient for patients with dementia.
Post-diagnostic management of individuals with mild de-
mentia mostly consisted of counselling relatives, testing
fitness-to-drive and minimising cardiovascular risk factors.
However, we also detected some gaps in post-diagnostic
support services for people with dementia and their carers,
as well as in certain aspects of GPs’ confidence in the diag-
nosis and management of dementia care. In particular, up
to one fifth of respondents did not feel confident with the
pharmacological treatment of patients with dementia, one
third felt insecure in coping with patients’ suicidal ideation
and half of respondents did not feel confident managing
patients with a migration background. Furthermore, one
quarter stated that the provision of care facilities for pa-
tients with dementia was insufficient.
One of the core areas of the Swiss National Dementia
Strategy [23] and a consensus conference on the diagnosis
and treatment of patients with dementia in Switzerland
[31] was to improve access to dementia diagnosis and to
stress the importance of early detection to help prepare
families for future challenges. Screening tests play a cru-
cial role in assessing cognitive impairment in general prac-
tice. Currently, the Mini-Mental State Examination
(MMSE [32];) is the most commonly used scale for the
assessment of cognitive disorders. This is also the case in
other European countries [33]. The case-finding ability of
the MMSE is best when confirming a suspected diagno-
sis in specialist settings [34]. However, in general prac-
tice, the utility of MMSE in the detection of dementia has
been challenged due to its false-positive rate of 86% when
adopting the cut-off point of 26. More stringent cut-off
points of 24 and 21 lead to some increase in the predic-
tive value in this sample, resulting in false-positive rates of
78% and 59% respectively [35]. Furthermore, there is lim-
ited evidence for detecting mild cognitive impairment with
the MMSE, with a sensitivity of 78.4% and a specificity
of 87.8 [34]. Therefore, the MMSE should not be used in
isolation to confirm or exclude dementia [33] or to iden-
tify MCI patients who could develop dementia [36]. The
current findings showed that the majority of respondents
used the MMSE in combination with the Clock Drawing
Test to assess cognitive functioning. This procedure shows
higher sensitivity and specificity in the detection of mild
Alzheimer’s disease than using the MMSE or the Clock
Drawing Test alone [37, 38].
For the detection of MCI, the use of both tests (MMSE
and Clock Drawing Test) still shows poor clinical utility
in general practice [37, 39]. An alternative method to as-
sess cognitive impairment is the Montreal Cognitive As-
sessment (MoCA [40];) [41]. The MoCA provides addi-
tional items measuring executive functions [42]. Results
from a meta-analysis indicated that the MoCA was the
best tool for the detection of mild cognitive impairment
among patients over 60 years of age when compared with
the MMSE [41]. For screening of cognitive impairment in
general practice, the MoCA threshold of 26 appeared opti-
mal [43].
The current findings indicate that only 17% of the respon-
dent GPs used this test when they had a clinical suspicion
of cognitive impairment. One reason for the frequent use
of the MMSE rather than another test to assess cognition
might be due to the fact that health insurance companies in
Figure 3: Regional differences in the perception of the provision of care and support facilities. The median across all cantons of Switzerland is
presented in the spatial plot (left), and across seven major Swiss regions in the boxplot (right). ++ = strongly agree with sufficient provision of
care and support facilities, +/- partially agree, -- strongly disagree with sufficient provision of care and support facilities.
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Switzerland suggest MMSE values to verify assumption of
costs for anti-dementia treatment. In addition, MoCA nor-
mative data have only very recently become available for
German-speaking Europe [44].
In 55% of European countries the diagnosis of dementia
frequently occurred at a moderate stage, which is currently
considered a late stage of diagnosis, when activities of dai-
ly living, relationships, behaviour and quality of life are
already significantly challenged by cognitive decline [24,
45]. In contrast, most Swiss GPs reported a mild stage of
dementia, with the MMSE ranging from 20-30 and diffi-
culties in activities of daily living, at the moment of first
diagnosis. This finding might be related to GPs’ collab-
oration with specialists such as memory clinics and neu-
rologists for further diagnostic assessments and their ac-
cess to diagnostic services. In Germany, recent results from
a cross-sectional survey indicated that early recognition
and dementia care management was highly appreciated by
GPs, who considered it feasible or wanted it to be imple-
mented in routine care [46]
A frank disclosure of the diagnosis of dementia helps the
patient and his/her caregivers to cope with the situation and
to develop a strategy for the future [47]. The diagnostic
disclosure requires time, in particular so that the patients’
deficiencies and resources, the social situation and his/her
biography can be understood. In this context, the current-
ly reported average of 30 minutes for disclosing a diagno-
sis seems adequate and necessary. Furthermore, the major-
ity of respondents reported disclosing the diagnosis to their
patients, and also informing both their patient and his/her
caregiver themselves. On the one hand, Australian GPs al-
so preferred disclosure to the patient with his/her caregiv-
er present due to issues of confidentiality and the impor-
tance of offering hope [10]. On the other hand, a German
study found that most GPs described difficulties disclos-
ing the diagnosis of dementia, and said that they were more
likely to give the diagnosis to family members rather than
to their patients, thereby avoiding the words ‘dementia’
or ‘Alzheimer’s’ in discussions [48].Thus, communicating
the diagnosis to the patient and his/her caregiver may raise
various ethical questions such as how to balance the differ-
ent communicative needs of patients and their caregivers,
clarity versus sensitivity in delivery of the diagnosis, and
whether to minimise or expose interactional difficulties
and misunderstanding to enrich patient understanding and
involvement [49]. Consequently, GPs need training and
guidance in delivering a diagnosis and in strategies to opti-
mise patient and caregiver participation [49].
The demographic changes accompanying an aging pop-
ulation will increase the demand for services, while re-
gional circumstances may hinder adequate access to health
care services. An Irish study showed that rural GPs felt
geographically disadvantaged when accessing diagnostic
services, and that both rural and urban GPs experienced
considerable time delays accessing specialist diagnostic
services [50]. In the current study, we could not find sys-
tematic differences in the access to diagnostic services
between rural and urban areas, but did find differences
between language regions. French-speaking GPs felt sig-
nificantly disadvantaged in their access to diagnostic ser-
vices. In particular, rural cantons such as Valais (n = 19),
Fribourg (n = 20) and Neuchâtel (n = 20) reported limited
access (see fig. 1). Consequently, the access to diagnostic
services should be improved in these regions.
We also found regional differences in the provision of care
facilities. GPs in the cantons of Jura and Uri reported in-
sufficient provision of care facilities (see fig, 3). These
findings are of particular importance since rural areas are
expected to experience accentuated aging due to the migra-
tion of young adults and the arrival of older people [51].
The major economic burden of dementia was found to be
the costs of care [52], which is why certain rural cantons
might lack cost-intensive care facilities. Our results sug-
gest that broader structural changes are needed in these ar-
eas, including day and night care and memory training to
better meet the needs of the elderly with dementia and their
families
GPs’ post-diagnostic strategies and interventions in the
early stages of dementia revealed a focus on non-pharma-
cological interventions including assessing fitness-to-dri-
ve, caregiver counselling and interventions to minimise
cardiovascular risk factors. On the one hand, testing fit-
ness-to-drive at the moment of diagnosis may also be a re-
verse cause mechanism: cognitive screening is often un-
dertaken at the time of the fitness-to-drive assessment and
reveals the dementia. On the other hand, the focus on as-
sessing fitness-to-drive is important since individuals with
mild dementia may have limited executive functions,
which may affect their driving aptitude [53]. However,
mild dementia does not a priori exclude the driving capa-
bility, as opposed to the case of moderate dementia, with
no further driving capability [53, 54]. Furthermore, test-
ing the driving capability entails certain challenges such
as concerns about damaging the patient-physician relation-
ship and uncertainties about the GP's own legal role [55].
In fact, almost half of the physicians in our survey would
welcome the option to delegate the assessment of fitness-
to-drive to an official authority. Nevertheless, Pentzek and
colleagues (2015) [55] recommended raising the issue of
driving in patients with dementia, since it is a prerequisite
for resource-oriented and patient-centred management.
The current study indicated that almost one fifth of GPs
felt unconfident with pharmacological treatment of their
patients and that symptomatic pharmacological treatment
was among the least frequently implemented post-diagnos-
tic actions in the case of mild dementia diagnosis. The
currently reported confidence levels in Swiss GPs align
with the confidence levels of German GPs [25]. GPs might
be insecure about the indication of and justification for
prescribing quite expensive drugs (except Gingko biloba)
with a rather low level of clinical effectiveness. In mild
to moderate Alzheimer's disease, results have been equiv-
ocal and no disease modifying agents are either licensed
or can be currently recommended for clinical use [56].
France has very recently stopped reimbursing anti-demen-
tia drugs, which is also in line with a recent systematic
review funded by the Agency for Healthcare Research
and Quality [57], which does not support pharmacological
treatment. Another possible explanation for the current
findings of rather low anti-dementia drug prescription by
Swiss GPs might be based on the potential negative im-
plications of polypharmacy and the side-effects for patient
safety. A recent Danish study indicated that people with
dementia were more frequently exposed to polypharmacy,
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as well as to potentially inappropriate medication [58].
Furthermore, a systematic review of a risk-benefit assess-
ment of dementia medications indicted that cholinergic
side effects were clinically significant and could be espe-
cially detrimental in the frail elderly population in which
the risks of treatment outweigh the benefits [59].
The current study found that GPs felt less confident in
managing patients with a migration background. A Dutch
study also described obstacles to the diagnosis of dementia
in non-western, elderly migrants in memory clinics [60].
The authors indicated that memory clinics were not well
prepared for non-western, elderly migrant patients. One
problem was that health professionals lacked knowledge
about important obstacles in intercultural dementia diag-
nostics such as language barriers, cultural differences, low
level of education and illiteracy, ignorance about dementia,
shame, and special care expectations of patients and their
families [60]. In Norway, there is evidence that immigrants
receive less dementia diagnosis and treatment than Nor-
wegians, indicating a lack of cultural validity of the as-
sessment tools, linguistic barriers and challenges for gen-
eral practitioners due to the migration background of their
patients [61]. Furthermore, studies of help-seeking among
various ethnic groups in the US have reported that many do
not prioritise dementia as a health issue, given more press-
ing concerns [62]. Consequently, GP training should con-
sider issues related to migration background as described
above.
Almost one third of respondents felt unconfident handling
suicidal ideation of patients with early dementia. Despite
the fact that risk of suicide in patients with dementia is
generally low, suicide is an important issue in dementia. A
recent review found that Alzheimer’s dementia was asso-
ciated with a moderate risk of suicide, even many years af-
ter the diagnosis of dementia [63]. Risk factors for suicide
are hopelessness, depression, mild cognitive impairment,
preserved insight, younger age, male gender, highly edu-
cated professional status, limitations in activities of dai-
ly living, economic stress, functional decline, and lack of
social support and a positive history of prior suicide at-
tempts [63–66]. Consequently, it was suggested that physi-
cians needed to consider the potential for suicide in vulner-
able individuals, particularly early in the dementia course
[63, 64], and emotional needs, especially in patients with
young onset Alzheimer’s disease [67]. According to Swiss
law, assisting suicide without any self-interest is legal [68].
Assisted suicide requires an attestation from a specialist
physician which attests the ability to judge. Since psychi-
atrists usually refuse to attest the ability to judge for such
purposes, GPs remain alienated as to how to cope with
their patients’ suicidal ideation in the case of early demen-
tia.
A limitation of this study was the response rate of 21%.
We chose a relatively time- and cost-effective method. In
view of this simple strategy, the length of the question-
naire (seven pages and a moderate total respondent burden
of 10-15 minutes for the completion of the questionnaire),
and other barriers to high response rates [69–71], participa-
tion was low. The current response rate is comparable with
a randomised study conducted in Western Switzerland and
in France, which compared GPs' response rates to a postal
versus a web-based survey, and showed a response rate of
22.47% (95% CI 21.07–23.87%) for the postal survey [72].
Although there is evidence that the preferred mode of sur-
vey administration is postal [73], response rates are gener-
ally low in general practice [74]. Therefore, representative
conclusions cannot be made for the current study. Never-
theless, the respondents did not differ from non-respon-
dents in terms of gender and age [75]. However, they did
differ in terms of language region, indicating a selection
bias towards German-speaking GPs. We cannot exclude
the possibility of confounding or alternative explanations
for our results, since the survey responses show subjective
attitudes and not objective performance. In particular, we
cannot exclude the possibility that more GPs participated
who were interested in or who were particularly affected
by the issue of dementia, and who felt there was a need for
such research. Furthermore, social desirability can induce
an over-reporting of positive attitudes in reply to questions
related to professional standards and behaviour. However,
if the confidence in the management of dementia patients
with migration background or with suicide ideation is al-
ready low in a very motivated sample, we would expect
them to be even lower in a sample including less motivat-
ed physicians with less interest in the topic. Therefore, de-
spite the low response rate, our findings that GPs lack con-
fidence in coping with suicidal ideation and with patients
with a migration background, suggesting a particular need
to support less experienced GPs, remains valid. A further
limitation is that we only assessed the attitudes of GPs on
early dementia recognition, omitting the patients’ and rel-
atives’ views on this topic. However, we believe that GPs
play a crucial role in designing and putting into practice
health services and health policy to increase the health out-
comes of their patients. Understanding and assessing GPs’
knowledge, attitudes, behaviours, practices and their views
on solutions to health care issues is vital to improving the
quality of health care. Nevertheless, our aim for future re-
search is to determine the attitudes of patients with mild
dementia and their relatives towards the disclosure of di-
agnoses of dementia and to explore their needs and experi-
ences regarding dementia management in general practice.
A strength of this study was the quantitative assessment of
a wide range of GPs’ practice patterns for the diagnosis,
disclosure and post-diagnostic management of dementia.
Our study identified gaps in Swiss GPs’ dementia practice
concerning dementia diagnostic assessment. GPs further
described difficulties in managing suicidal ideation and de-
mentia patients with a migration background. Moreover,
regional variations in health care provision were detected.
Our findings may enable the definition of policy priorities
to provide training and information, as well as to establish
access to diagnostic services and provision of care and sup-
port facilities.
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Appendix 1 Supplementary tables
Table S1: Frequency of statements about diagnostic assessment and disclosure.
Statements Frequent
n (%)
50% of cases
n (%)
Not frequent
n (%)
Mdn IQR
Reasons for early diagnostic assessment of cognitive decline:
Relatives report cognitive impairment or behavioural problems 490(57) 205(24) 172(19) 75% 50‒75%
Screening test 64(8) 105(13) 635(79) 25% 0‒25%
Patient complains about cognitive decline 420(49) 185(21) 262(30) 50% 25‒100%
GP detects cognitive decline 378(45) 191(23) 278(33) 50% 25–75%
Official occasion (e.g., test fitness-to-drive, establishing the last will, ad-
vance directive, etc.)
276(33) 123(15) 440(52) 25% 0–50%
GP discloses him/herself the dementia diagnosis to the patient 654(74) 148(17) 77(9) 75% 50–100%
IQR = interquartile range; Mdn = median 100% indicates always, 0% never, 50% indicates half of the time.
Table S2: Agreement with statements about confidence in different situations of managing patients with dementia.
Statements Agree
n (%)
Partially agree
n (%)
Disagree
n (%)
Mdn IQR
I feel confident in the provision of care for patients with cognitive impairment 573 (65) 245 (28) 60 (7) 4 3–4
I feel confident in the early diagnostic assessment of patients with cognitive impair-
ment.
561 (64) 228 (26) 91 (10) 4 2‒3
I feel confident in the pharmacological treatment of patients with cognitive impair-
ment.
467 (53) 252 (29) 157 (18) 4 3‒4
I would like to delegate the assessment of fitness-to-drive of patients with cognitive
impairment to an official authority.
421 (48) 137 (16) 317 (36) 3 2–5
Suicide ideation of patients with cognitive impairment make me insecure 264 (30) 225 (26) 384 (44) 3 2–4
I feel confident in caring and supporting for patients with dementia with migration
background
135 (16) 302 (35) 415 (49) 3 3–4
I feel confident in the early diagnostic assessment of patients with cognitive impair-
ment and migration background
122 (15) 285 (33) 450 (52) 2 2–3
IQR = interquartile range; Mdn = median
Table S3: Agreement with statements about regional provision with health care facilities.
Statements Agree
n (%)
Part-ially
agree
n (%)
Disagree
n (%)
Mdn IQR
The access to diagnostic services for referring patients with cognitive impairment is suffi-
cient.
644 (74) 120 (14) 112 (13) 4 3–5
In my catchment area, the provision with care facilities is insufficient for patients with cogni-
tive impairment.
218 (25) 207 (24) 449 (51) 2 2–3
IQR = interquartile range; Mdn = median
Table S4: Frequency of strategies/ interventions after a diagnosis of mild dementia.
Strategies Frequent
n (%)
50% of cases
n (%)
Not frequent
n (%)
Mdn IQR
Counselling of relatives 613(71) 159(18) 92(11) 75 50–100
Assessment of driving aptitudes 555(66) 131(16) 153(18) 75 50–100
Measures to minimise cardiovascular risks 528(63) 156(19) 149(18) 75 50–100
Prepare advanced directives or to designate a power of trustee 386(46) 202(24) 259(31) 50 25–75
Memory training activities 351(42) 166(20) 321(38) 50 25–75
Prescription of Ginkgo biloba 308(36) 163(19) 381(45) 50 25–75
Refer patient to counselling centre e.g. Alzheimer's association 296(35) 226(27) 325(38) 50 25–75
Pharmacological mono therapy (i.e., acetylcholinesterase inhibitors or meman-
tine)
235(29) 209(25) 388(47) 50 25–75
Other non-pharmacological treatments (involving music-, painting, dancing,
coaching strategies or conversations to cope with the situation)
174(21) 147(18) 510(61) 25 0–50
Wait-and-see strategy with no intervention 161(21) 167(21) 464(58) 25 25–50
Home visits to assess specific living conditions 91(12) 124(17) 526(71) 25 0–50
Pharmacological combination therapy (i.e. acetylcholinesterase inhibitors and
memantine)
21(3) 41(5) 710(92) 0 0–25
IQR = interquartile range; Mdn = median 100% indicates always, 0% never, 50% indicates half of the time.
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Table S5: Most required care facilities for patients with cognitive impairment in the catchment area.
Item From total
(n = 882)
From GPs not satisfied with care facilities
(n = 218)
n % n %
Memory or activation therapy 409 46.37 127 58.26
Holidays for people with dementia 383 43.42 100 45.87
Night care centre 379 42.97 111 50.92
Day care centre 364 41.27 127 58.26
Voluntary aids 322 36.51 102 46.79
Day and night care centre 238 26.98 87 39.91
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